Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
PetMed Express board raises quarterly dividend to 28c per share » 08:44
05/04/20
05/04
08:44
05/04/20
08:44
PETS

PetMed Express

$38.57 /

-1 (-2.53%)

The Board of Directors…

The Board of Directors declared an increased quarterly dividend from $0.27 to $0.28 per share on its common stock. The dividend will be payable on May 22, 2020, to shareholders of record at the close of business on May 15, 2020. The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company's financial performance.

ShowHide Related Items >><<
PETS PetMed Express
$38.57 /

-1 (-2.53%)

04/09/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
03/12/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
Earnings
PetMed Express reports Q4 EPS 35c, two est. 29c » 08:43
05/04/20
05/04
08:43
05/04/20
08:43
PETS

PetMed Express

$38.57 /

-1 (-2.53%)

REports Q4 revenue…

REports Q4 revenue $74.3M, two est. $66.24M. Reorder sales for the three months ended March 31, 2020 were $65.2 million, compared to $55.9 million for the three months ended March 31, 2019, an increase of 17%. New order sales for the three months ended March 31, 2020 were $9.1 million, compared to $8.7 million for the three months ended March 31, 2019, an increase of 5%. The Company acquired approximately 107,000 new customers in the quarter ended March 31, 2020, compared to 101,000 new customers in the same period the prior year. The average order size for the quarter ended March 31, 2020 was $90, compared to $85 for the quarter ended March 31, 2019. Menderes Akdag, President and CEO, commented: "During the March quarter, due to COVID-19, demand has been strong for the ecommerce channel, with consumers shifting their purchases to online, which has positively impacted our sales. We were more efficient with our advertising in the fourth quarter, and we will continue to focus on optimizing our marketing plan in fiscal 2021. As an essential business, we have been open during our normal business hours without any material disruptions in our operations. We are dedicated to making every effort to ensure pets get the medications they need in these challenging times. We have also taken extra precautions to ensure the health and safety of our employees. Also, so far, we have not seen any material disruptions in our supply chain. But, as it is a fluid situation, we are monitoring and managing it closely. In fiscal 2021, we will continue to be price competitive and will increase advertising to acquire new customers, promote brand awareness, and reinforce brand loyalty."

ShowHide Related Items >><<
PETS PetMed Express
$38.57 /

-1 (-2.53%)

04/09/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
03/12/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
Downgrade
PetMed Express downgraded to Neutral from Buy at Sidoti » 08:41
04/09/20
04/09
08:41
04/09/20
08:41
PETS

PetMed Express

$29.35 /

+1.48 (+5.31%)

Sidoti analyst Anthony…

Sidoti analyst Anthony Lebiedzinski downgraded PetMed Express to Neutral from Buy with a $31 price target. He expects "fierce competition" in the company's pet medicines and supplies space to continue, the analyst stated.

ShowHide Related Items >><<
PETS PetMed Express
$29.35 /

+1.48 (+5.31%)

03/12/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
Over a quarter ago
Upgrade
PetMed Express upgraded to Buy from Neutral at Sidoti » 13:53
03/12/20
03/12
13:53
03/12/20
13:53
PETS

PetMed Express

$24.74 /

-1.3 (-4.99%)

Sidoti analyst Anthony…

Sidoti analyst Anthony Lebiedzinski upgraded PetMed Express to Buy from Neutral with a $31 price target.

ShowHide Related Items >><<
PETS PetMed Express
$24.74 /

-1.3 (-4.99%)

02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
08/16/19 Craig-Hallum
PetMed Express upgraded to Hold from Sell at Craig-Hallum
Downgrade
PetMed Express downgraded to Neutral from Buy at Sidoti » 08:46
02/24/20
02/24
08:46
02/24/20
08:46
PETS

PetMed Express

$28.58 /

+0.25 (+0.88%)

, CHWY

Chewy

$30.44 /

+1.155 (+3.94%)

Sidoti analyst Anthony…

Sidoti analyst Anthony Lebiedzinski downgraded PetMed Express (PETS) to Neutral from Buy with an unchanged price target of $31. The shares have rallied 90% since reaching a 52-week low of $15 on July 12, leaving limited upside potential, noted Lebiedzinski. The analyst also noted that competition will remain "fierce," especially from Chewy.com (CHWY).

ShowHide Related Items >><<
PETS PetMed Express
$28.58 /

+0.25 (+0.88%)

10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
08/16/19 Craig-Hallum
PetMed Express upgraded to Hold from Sell at Craig-Hallum
07/15/19 Craig-Hallum
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
CHWY Chewy
$30.44 /

+1.155 (+3.94%)

02/24/20 Evercore ISI
Chewy initiated with an Outperform at Evercore ISI
02/21/20
Fly Intel: Top five analyst upgrades
02/21/20 RBC Capital
Chewy upgraded to Outperform from Sector Perform at RBC Capital
01/27/20 Wedbush
Chewy upgraded to Outperform at Wedbush on online pet industry sales growth
Earnings
PetMed Express reports Q3 EPS 34c, two est. 30c » 08:17
01/21/20
01/21
08:17
01/21/20
08:17
PETS

PetMed Express

$27.28 /

+0.76 (+2.87%)

Reports Q3 revenue…

Reports Q3 revenue $59.9M, two est. $61.31M. Average order size increased to $85 for the quarter ended December 31, 2019, compared to $84 for the same quarter in the prior year. Reorder sales increased 1.0%, to $53.8 million for the quarter ended December 31, 2019, compared to $53.3 million for the same quarter in the prior year. Menderes Akdag, CEO and President, commented: "We were encouraged with improvements to our average order size, and gross and net income margins during the quarter. Gross margins improved by 90 basis points from 28.6% in the September quarter to 29.5% in the December quarter. Net income margins improved 180 basis points from 9.6% in the September quarter to 11.4% in the December quarter. The gross margin increase can be attributed to our success in obtaining direct purchasing relationships with all the major manufacturers, and the implementation of the minimum advertised price policy by those manufacturers. We anticipate MAP pricing to stabilize pet medication prices throughout the online channel. Net cash from operations for the nine months ended December 31, 2019 was $21.6 million. In 2020, we will focus on optimizing our marketing in this more competitive environment and being more efficient with our advertising spending. In addition, we will continue investing in our e-commerce platform to better service our customers. This platform will enable us to improve upon our already strong net promoter score of 84.0%. We believe this customer satisfaction measure reflects the strong bond we have with our customers and will assist the Company with future customer retention."

ShowHide Related Items >><<
PETS PetMed Express
$27.28 /

+0.76 (+2.87%)

10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
08/16/19 Craig-Hallum
PetMed Express upgraded to Hold from Sell at Craig-Hallum
07/15/19 Craig-Hallum
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
Conference/Events
PetMed Express management to meet with Sidoti » 04:55
12/10/19
12/10
04:55
12/10/19
04:55
PETS

PetMed Express

$22.76 /

+0.43 (+1.93%)

Meetings to be held in…

Meetings to be held in Boston on December 9 and in New York on December 10 hosted by Sidoti.

ShowHide Related Items >><<
PETS PetMed Express
$22.76 /

+0.43 (+1.93%)

10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
08/16/19 Craig-Hallum
PetMed Express upgraded to Hold from Sell at Craig-Hallum
07/15/19 Craig-Hallum
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
Conference/Events
PetMed Express management to meet with Sidoti » 04:55
12/09/19
12/09
04:55
12/09/19
04:55
PETS

PetMed Express

$22.33 /

+0.42 (+1.92%)

Meetings to be held in…

Meetings to be held in Boston on December 9 and in New York on December 10 hosted by Sidoti.

ShowHide Related Items >><<
PETS PetMed Express
$22.33 /

+0.42 (+1.92%)

10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
08/16/19 Craig-Hallum
PetMed Express upgraded to Hold from Sell at Craig-Hallum
07/15/19 Craig-Hallum
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
Conference/Events
PetMed Express management to meet with Sidoti » 11:06
12/05/19
12/05
11:06
12/05/19
11:06
PETS

PetMed Express

$21.87 /

+0.145 (+0.67%)

Meetings to be held in…

Meetings to be held in Boston on December 9 and in New York on December 10 hosted by Sidoti.

ShowHide Related Items >><<
PETS PetMed Express
$21.87 /

+0.145 (+0.67%)

10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
08/16/19 Craig-Hallum
PetMed Express upgraded to Hold from Sell at Craig-Hallum
07/15/19 Craig-Hallum
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
On The Fly
Fly Intel: Wall Street's top stories for Monday » 17:04
10/21/19
10/21
17:04
10/21/19
17:04
BA

Boeing

$331.12 /

-12.97 (-3.77%)

, ABC

AmerisourceBergen

$86.54 /

-3.13 (-3.49%)

, MKC

McCormick

$162.36 /

+0.76 (+0.47%)

, CAH

Cardinal Health

$50.40 /

-1.24 (-2.40%)

, TEVA

Teva

$8.15 /

+0.65 (+8.67%)

, IPHS

Innophos Holdings

$32.18 /

-3.18 (-8.99%)

, COTY

Coty

$11.46 /

+1.34 (+13.24%)

, YNDX

Yandex

$32.78 /

+3.03 (+10.18%)

, PETS

PetMed Express

$26.02 /

+6.57 (+33.78%)

, INFY

Infosys

$9.30 /

-1.27 (-12.02%)

, PTON

Peloton

$22.26 /

-1.18 (-5.03%)

Stocks were higher…

Open Full Text

ShowHide Related Items >><<
BA Boeing
$331.12 /

-12.97 (-3.77%)

10/21/19
Fly Intel: Top five analyst downgrades
10/21/19 Stifel
JetBlue could be worth $28 in a takeout scenario, says Stifel
10/21/19 Stifel
Stifel downgrades Southwest on risk of deal to lessen Boeing dependency
10/21/19 Baird
Baird cuts Boeing to Neutral following 'Textgate'
ABC AmerisourceBergen
$86.54 /

-3.13 (-3.49%)

10/16/19 Jefferies
Drug distributor settlement would make stocks 'ownable again,' says Jefferies
10/16/19 Jefferies
Drug distributor settlement would make stocks 'ownable again,' says Jefferies
10/16/19 Barclays
Barclays ups McKesson target on probability of favorable settlement
09/11/19 Deutsche Bank
AmerisourceBergen initiated with a Hold at Deutsche Bank
MKC McCormick
$162.36 /

+0.76 (+0.47%)

10/02/19 Credit Suisse
McCormick price target raised to $160 from $150 at Credit Suisse
08/20/19
Fly Intel: Top five analyst downgrades
08/20/19 JPMorgan
McCormick downgraded to Underweight at JPMorgan, price target lowered to $150
08/20/19 JPMorgan
McCormick downgraded to Underweight from Neutral at JPMorgan
CAH Cardinal Health
$50.40 /

-1.24 (-2.40%)

09/11/19 Deutsche Bank
Cardinal Health initiated with a Hold at Deutsche Bank
TEVA Teva
$8.15 /

+0.65 (+8.67%)

10/17/19
Fly Intel: Top five analyst upgrades
10/17/19 Gabelli
Gabelli upgrades Teva to Buy as global opioid settlement appears more likely
10/16/19 Gabelli
Teva upgraded to Buy from Hold at Gabelli
10/03/19 Piper Sandler
Bausch unlikely to face generic Xifaxan before 2028, says Piper Jaffray
IPHS Innophos Holdings
$32.18 /

-3.18 (-8.99%)

02/21/19 Seaport Global
Innophos Holdings initiated with a Buy at Seaport Global
COTY Coty
$11.46 /

+1.34 (+13.24%)

10/21/19 Stifel
Coty price target raised to $11.50 from $10 at Stifel
10/21/19 Jefferies
Jefferies expresses mixed view of Coty's unit sale plans
07/02/19 JPMorgan
Coty turnaround plan requires patience, says JPMorgan
07/02/19 Citi
Coty downgraded to Sell from Neutral at Citi
YNDX Yandex
$32.78 /

+3.03 (+10.18%)

10/14/19 BofA
Foreign ownership limit worries create opportunity to buy Yandex, says BofA
10/11/19 UBS
Negative market reaction on Yandex 'overdone,' says UBS
06/27/19 OTR Global
Yandex initiated with a Positive at OTR Global
06/11/19 VTB Capital
Yandex upgraded to Buy from Hold at VTB Capital
PETS PetMed Express
$26.02 /

+6.57 (+33.78%)

10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
08/16/19
Fly Intel: Top five analyst upgrades
08/16/19 Craig-Hallum
PetMed Express upgraded to Hold from Sell at Craig-Hallum
07/15/19 Craig-Hallum
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
INFY Infosys
$9.30 /

-1.27 (-12.02%)

10/21/19 Baird
Infosys 'becoming more interesting' if whistleblower immaterial, says Baird
10/15/19 Credit Suisse
Wipro upgraded to Neutral after earnings at Credit Suisse
10/14/19 ICICI Securities
Infosys downgraded to Hold from Add at ICICI Securities
09/16/19 UBS
Infosys downgraded to Neutral from Buy at UBS
PTON Peloton
$22.26 /

-1.18 (-5.03%)

10/21/19 JPMorgan
Peloton initiated with an Overweight at JPMorgan
10/21/19 KeyBanc
Peloton initiated with an Overweight at KeyBanc
10/21/19 William Blair
Peloton initiated with an Outperform at William Blair
10/21/19 Goldman Sachs
Peloton initiated with a Buy at Goldman Sachs

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.